Sponsor Pipeline

Beijing Boren Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
6
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 1
1
Early Phase 1
3
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07361094 Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases Relapsed/Refractory Systemic Lupus Erythematosus Recruiting
Early Phase 1
NCT07448298 A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases Relapsed/Refractory Autoimmune Diseases Recruiting
NCT07626476 Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain… Relapsed/Refractory Light Chain Amyloidosis Recruiting
NCT07502859 A Study of BEN301 Injection in the Treatment of Autoimmune Diseases SSC RA SS IIM Not Yet Recruiting
Not specified
NCT06983951 Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART… Light Chain Amyloidosis Recruiting
NCT06983964 Safety and Efficacy of CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases Autoimmune Disease Recruiting
NCT06993493 Autologous CD19CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases Autoimmune Disease Recruiting
NCT06661811 A Study of CAR-T Cells Targeting Autoimmune Diseases Autoimmune Diseases Not Yet Recruiting
Disease Areas
Get alerts when Beijing Boren Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free